One2Treat’s patented software, harnessing advances in computing power, combined with deep clinical research expertise, allows you to review multiple insights and grow future opportunities. Our regulatory-approved approach makes previously invisible insights visible and elevates your understanding of Net Treatment Benefit in a single analysis. The Generalized Pairwise Comparisons (GPC) method reveals more dimensions of treatment effects to improve future trial design.
Want to invest in a more holistic understanding of Net Treatment Benefit?